Since 2002, Life Science Partner has combined scientific knowledge with business discipline to identify and recruit the brightest talent, provide strategic advice, and connect companies with the right candidates to make their enterprises more successful. Our targeted, high quality executive search services meet the specific needs of medical device, biotechnology and pharmaceutical companies, and healthcare organizations.
We have a designed a unique and thorough approach to bringing our clients the transformational leaders needed to take their business to the next level:
- Learn about your company and your needs – including the corporate culture and factors for success in the role
- Create a job description that captures the opportunity to attract the best and most-qualified talent
- Strategically research, identify, and contact prospective candidates and sources
- Assess our best prospective candidates via telephone, Skype, and face-to-face interviews
- Update you with continuous feedback on our progress in weekly meeting written reports and telephone calls
- Provide you with candidate assessment letters that convey our recommendations and reservations
- Conduct in-depth references on the leading candidates with a written report
- Assist you in the negotiation of an acceptable offer, with a fiduciary responsibility to you, our client
- Partner with you to ensure a successful transition into the new role including a one-year search-again guarantee of success
Tom Callaway, MD, MBA
Founder and Partner
Prior to starting Life Science Partner, Tom led the Emerging Health Technologies practice at Korn/Ferry International, where he was Managing Director. Tom primarily recruited top-level executives for and at Russell Reynolds where he earned a reputation for quickly grasping new technologies and successfully recruiting top scientists and business leaders.
Tom is also a partner with HealthQuest Capital, a venture capital firm targeting growth-stage medical device, diagnostics, healthcare IT, and consumer healthcare companies. HQC is especially interested in innovations that provide benefits that can be quantified in terms of both improvements in patient care and outcomes, as well as healthcare economics.
Prior to his career in executive placement, Tom served as Director of Commercial Development for SyStemix, where he established technology developmental partnerships with major cancer centers including M.D. Anderson, Fred Hutchinson Cancer Research Center, and the Mayo Clinic. SyStemix developed proprietary stem cell purifying technologies important for treatment of cancer and genetic illnesses. He was the liaison with Sandoz’s oncology group, whose parent company completed its acquisition of the company in 1996.
Tom began his biotechnology career at Roche Biomedical and Roche Molecular Systems, developing and executing a global marketing plan for polymerase chain reaction (PCR) diagnostics technology. In partnership with Duke University Medical Center, Tom conceived and organized the first international conference on the clinical applications of PCR for HIV detection.
Tom earned his Doctorate of Medicine at Vanderbilt University and both his undergraduate degree and MBA at Duke University. Active in the Southeast community, he sits on the boards of Southeast BIO (past chairman) and of the Park H. Petit Institute for Bioengineering and Bioscience at Georgia Tech, and helped found the Southeast Medical Device Association. Tom’s personal interests include kiteboarding, tennis, international travel, Duke basketball, discussing big ideas in healthcare & technology, and spending time with his family.